[HTML][HTML] Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors

S Kobayashi, HM Canepa, AS Bailey… - Journal of Thoracic …, 2013 - Elsevier
… In summary, compound EGFR mutations comprised 14% of all mutations identified during …
18 to 21 of EGFR in our cohort. Most tumors with an EGFR sensitizing mutation (G719X, exon …

Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma

EY Kim, EN Cho, HS Park, JY Hong, S Lim… - Cancer biology & …, 2016 - Taylor & Francis
… actionable oncogenic mutations. This study shows that the compound EGFR mutation is
common in lung adenocarcinoma and imparts a new meaning of compound EGFR mutation. …

[HTML][HTML] Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence

I Attili, A Passaro, P Pisapia, U Malapelle… - Current Oncology, 2022 - mdpi.com
… the issue of the distribution of compound EGFR mutations. For this purpose, according to …
main categories of compound EGFR mutations: combined common EGFR mutations (exon 21 p.…

[HTML][HTML] First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution's clinical practice …

X Yu, X Zhang, Z Zhang, Y Lin, Y Wen, Y Chen… - Cancer …, 2018 - Springer
… We divided the cohort with the compound EGFR mutations into … mutations sites reported
in the literature: a double common mutation group (5/106, 4.7%), a common plus rare mutation

Clinicopathological characteristics of lung adenocarcinoma with compound EGFR mutations

T Hayashi, S Kohsaka, K Takamochi, K Hara… - Human Pathology, 2020 - Elsevier
… with compound EGFR mutations. We compared compound EGFR mutations with
common or uncommon single-mutation cases. Our study expands the comprehension of the …

Comparison of uncommon EGFR exon 21 L858R compound mutations with single mutation

L Peng, Z Song, S Jiao - OncoTargets and therapy, 2015 - Taylor & Francis
… The most classic mutations have been well investigated, while few studies have focused on
EGFR mutations such as compound EGFR mutations where two or even more mutations

A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer

HY Tu, EE Ke, JJ Yang, YL Sun, HH Yan, MY Zheng… - Lung Cancer, 2017 - Elsevier
EGFR mutations and their sensitivity to EGFR-TKIs. Favorable responses were observed in
patients with G719X and compound L858R mutations, … of compound EGFR mutations in this …

The in cis compound EGFR mutations in Chinese advanced non-small cell lung cancer patients

M Li, CZ Zhou, JJ Yang, S Lu, D Zheng… - Cancer Biology & …, 2019 - Taylor & Francis
… cis compound EGFR mutation and single EGFR L858R. We randomly selected 23 patients
from our screened cohort harboring single EGFR … with in cis compound EGFR mutation. The …

[PDF][PDF] Successful treatment of a patient with lung adenocarcinoma harboring compound EGFR gene mutations, G719X and S768I, with Afatinib

N Kutsuzawa, F Takahashi, K Tomomatsu… - Tokai J Exp Clin …, 2020 - mj-med-u-tokai.com
… lung adenocarcinoma harboring compound uncommon EGFR mutations, G719X in exon 18
… efficacy of EGFR-TKIs in lung cancers harboring rare compound EGFR mutations cannot be …

Uncommon single and compound EGFR mutations: Clinical outcomes of a heterogeneous subgroup of NSCLC

S Rossi, P Damiano, L Toschi, G Finocchiaro… - Current Problems in …, 2022 - Elsevier
… uncommon EGFR mutations (single or compound mutation). Patients were treated with EGFR
Median OS resulted longer in the compound mutation group when compared to single rare …